- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/24 - Follicle-stimulating hormone [FSH]Chorionic gonadotropins, e.g. HCGLuteinising hormone [LH]Thyroid-stimulating hormone [TSH]
Patent holdings for IPC class A61K 38/24
Total number of patents in this class: 459
10-year publication summary
|
36
|
29
|
29
|
21
|
33
|
26
|
27
|
19
|
32
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 710 |
60 |
| Opko Biologics Ltd. | 79 |
18 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 65 |
10 |
| Amunix Pharmaceuticals, Inc. | 89 |
8 |
| CEVA Sante Animale | 723 |
7 |
| The Wistar Institute of Anatomy and Biology | 484 |
6 |
| Butterfly Biosciences, Inc. | 15 |
6 |
| Biotempt B.V. | 27 |
5 |
| Neuralight HD, LLC | 7 |
5 |
| Therio, LLC | 6 |
5 |
| The Regents of the University of California | 20815 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6687 |
4 |
| ASKA Pharmaceutical Co., Ltd. | 96 |
4 |
| AspenBio Pharma, Inc. | 6 |
4 |
| Ferring International Center S.A. | 41 |
4 |
| Glycotope GmbH | 67 |
4 |
| Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | 176 |
4 |
| LTS Lohmann Therapie-Systeme AG | 675 |
4 |
| New York University | 1845 |
4 |
| Trophogen, Inc. | 13 |
4 |
| Other owners | 289 |